title: Protein antioxidants in thalassemia.
abstract: It is common knowledge that thalassemic patients are under significant oxidative stress. Chronic hemolysis, frequent blood transfusion, and increased intestinal absorption of iron are the main factors that result in iron overload with its subsequent pathophysiologic complications. Iron overload frequently associates with the generation of redox-reactive labile iron, which in turn promotes the production of other reactive oxygen species (ROS). If not neutralized, uncontrolled production of ROS often leads to damage of various intra- and extracellular components such as DNA, proteins, lipids, and small antioxidant molecules among others. A number of endogenous and exogenous defense mechanisms can neutralize and counteract the damaging effects of labile iron and the reactive substances associated with it. Endogenous antioxidant enzymes, such as superoxide dismutase, catalase, glutathione peroxidase, and ferroxidase, may directly or sequentially terminate the activities of ROS. Nonenzymatic endogenous defense mechanisms include metal binding proteins (ceruloplasmin, haptoglobin, albumin, and others) and endogenously produced free radical scavengers (glutathione (GSH), ubiquinols, and uric acid). Exogenous agents that are known to function as antioxidants (vitamins C and E, selenium, and zinc) are mostly diet-derived. In this review, we explore recent findings related to various antioxidative mechanisms operative in thalassemic patients with special emphasis on protein antioxidants.
authors.affiliation: Department of Medical Laboratory Sciences, College of Health Sciences, University of Sharjah, Sharjah, United Arab Emirates. sawadallah@sharjah.ac.ae
authors.forename: Samir
authors.initials: S
authors.lastname: Awadallah
mesh_terms: D000975:Antioxidants / Q000378:metabolism* / Q000494:pharmacology; D015415:Biomarkers / Q000032:analysis / Q000378:metabolism; D001803:Blood Transfusion; D002986:Clinical Trials as Topic; D004798:Enzymes / Q000378:metabolism; D006461:Hemolysis; D006801:Humans; D007408:Intestinal Absorption; D007501:Iron / Q000378:metabolism*; D019190:Iron Overload; D018384:Oxidative Stress; D011506:Proteins / Q000378:metabolism*; D013789:Thalassemia / Q000378:metabolism* / Q000503:physiopathology / Q000628:therapy*
chemical_list: D000975:Antioxidants; D015415:Biomarkers; D004798:Enzymes; D011506:Proteins; D007501:Iron